bg
A

Allovir (ALVR)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Allovir (ALVR)

AlloVir, Inc. is a late clinical-stage cell therapy company. The Company is engaged in developing allogeneic T-cell therapies to treat and prevent viral diseases. Its virus-specific T cell (VST) therapy platform enables to generate VSTs designed to r... Read more

  • USD4.53
  • USD5.99
  • USD4.43
  • USD10.29
  • 1.10%
  • --
  • 834.00
  • 180.33k
  • 371M
  • 3.17
  • 20.50%

Unlock More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.